Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08517-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Margaux Damerval und 13 weiteren Autor:innen. Beteiligte Einrichtung: CHU Besançon, Pôle Pharmacie, 25030, Besançon, France. Hauptthemen laut MEDLINE: Patient Preference, Focus Groups, Delphi Technique, Choice Behavior. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. They are conditioned by the needs, expectations, and involvement of the patients in their care. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is a method recommended by the ISPOR for such a task. The "selection and validation of attributes and their values" step is fundamental in this process. In this context, the aim of this study was to present our research approach to identify and validate the attributes that characterize an OPC and their values. METHODS: Due to the lack of relevant published data in the literature, the focus-group method was used in accordance with good research practices for the application of conjoint-analysis of the ISPOR. The two-round Delphi method was used to validate the attributes and their values identified by the focus-group method. RESULTS: The focus-group method enabled identification of nine attributes. Thirty-seven healthcare professionals at a national level, including 30 pharmacists and seven physicians, were selected to take part in the Delphi procedure. Seven attributes (frequency, planification, operation mode, duration, content, written support, and report) and their values were thus validated. CONCLUSION: Based on these results, the next step will be to elicit patient preferences for OPCs and to then shed light on the issues of pharmaceutical support for patients by comparing their preferences with those of informal caregivers and, in particular, those of the healthcare professionals involved in their care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU Besançon, Pôle Pharmacie, 25030, Besançon, France.
- Qualees, Paris, France.
- Department of Pharmacy, Hospices Civils de Lyon, UCBL1, EA3738 CICLY, F-69002, Lyon, France.
- Department of Pharmacy, Hôpital Nord Franche-Comté, Site de Belfort, 90400, Trévenans, France.
- Assistance Pour Le Traitement des Urémiques en Provence-Corse, Centre de Néphrologie Marseille Borde, 13008, Marseille, France.
- Department of Pharmacy, Institut de Cancérologie Strasbourg Europe, 67200, Strasbourg, France.
Zitieren
APA
Damerval, M., Bennani, M., Rioufol, C., Omrani, S., Riboulet, M., Etienne-Selloum, N., Saint-Ghislain, A., Leenhardt, F., Schmitt, A., Simon, N., Clairet, A. L., Meurisse, A., French Implication Expert Panel, & Nerich, V. (2024). Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08517-z
Vancouver
Damerval M, Bennani M, Rioufol C, Omrani S, Riboulet M, Etienne-Selloum N, et al. Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08517-z
BibTeX
@article{Damerval2024,
author = {Damerval, Margaux and Bennani, Mohammed and Rioufol, Catherine and Omrani, Selim and Riboulet, Margaux and Etienne-Selloum, Nelly and Saint-Ghislain, Audrey and Leenhardt, Fanny and Schmitt, Antonin and Simon, Nicolas and Clairet, Anne-Laure and Meurisse, Aurélia and French Implication Expert Panel, French Implication Expert Panel and Nerich, Virginie},
title = {Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08517-z}
}
EUVIMED